World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences


Login | Registration


ISSN: 2583-6579


Impact Factor: 5.111

ABSTRACT

HIGH PERFORMANCE CHROMATOGRAPHIC (GPC) METHOD FOR THE ESTIMATION OF DIACEREIN IN SOLID DOSAGE FORMS

Raveendran K. C.*

Diacerein is now widely used for the treatment of Osteoarthritis. The mechanism of action differs from the Nonsteroidal anti-inflammatory drugs since it is not related to the inhibition of Prostaglandins. Anti-osteoarthritis and cartilage stimulating properties have been demonstrated in vivo and in animal models. Diacerein and Rhein have been shown to inhibit the production of interleukin-I beta by human monocytes and the effects of the cytokine on chondrocytes in vivo. Diacerein in therapeutic dose inhibit the stimulation of interleukin-1 beta production and production of nitrous oxide. It also significantly reduces severity of pathological changes of osteoarthritis compared to placebo and increases the expression of transforming growth factor TGF-beta-1 and TGF beta-2 with potential cartilage repairing properties. From the literature, Diacerein is seemed to be a safe and promising drug. This research work has been taken up to develop and validate simple, accurate, sensitive and cost-effective methods for the estimation of Diacerein in dosage forms. A new LC method with UV detection was developed for the quantitative determination of Diacerein in pharmaceutical dosage forms. The chromatographic separation was performed on GPC column with a mobile phase of tetra hydro furan. A flow rate of 1.2ml/minute was used. The resulting chromatogram exhibited a retention time of 5.784 minute. The limit of detection and limit of quantification was found to be 0.5μg/m land 1μg/ml. A linearity range of 1-10μg/ml was established. The correlation coefficient was found to be 1. 007.The results of analysis were treated statically, as per ICH guidelines for validation of analytical procedures and by recovery studies. The results were found to be accurate and not much interferences from capsule excipients. The active pharmaceutical ingredient was extracted from its finished dosage forms using tetrahydrofuran. The percentage recovery was found to be 99.9%w/w.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our IMPACT FACTOR has increased from 3.454 to 5.111

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    January 2026 Issue Now Available

    January 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming January 2026 Issue . All submissions will undergo a standard peer-review process.